|
|
Multiple sclerosis: effect of beta interferon treatment on survival
Elaine Kingwell
,
Emmanuelle Leray
,
Feng Zhu
,
John Petkau
,
Gilles Edan
,
et al.
Journal articles
hal-02088095v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Criteria improving multiple sclerosis diagnosis at the first MRI
Nathalie Caucheteux
,
Adil Maarouf
,
Margaux Genevray
,
Emmanuelle Leray
,
Romain Deschamps
,
et al.
Journal articles
hal-01378308v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Use of healthcare services by patients with multiple sclerosis in France over 2010-2015: a nationwide population-based study using health administrative data
Jonathan Roux
,
Alice Guilleux
,
Mathilde Lefort
,
Emmanuelle Leray
Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2019, 5 (4), pp.2055217319896090. ⟨10.1177/2055217319896090⟩
Journal articles
hal-02444012v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses
Maxime Jeanjean
,
Marie-Abele Bind
,
Jonathan Roux
,
Jean-Claude Ongagna
,
Jérôme de Sèze
,
et al.
Journal articles
hal-01740486v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Emmanuelle Leray
,
M. Coustans
,
Emmanuelle Le Page
,
J. Yaouanq
,
Joel Oger
,
et al.
Journal articles
hal-00878705v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
David-Axel Laplaud
,
Romain Casey
,
Laetitia Barbin
,
Marc Debouverie
,
Jerome de Sèze
,
et al.
Journal articles
inserm-02289153v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society
C. Lebrun
,
S. Vukusic
,
V. Abadie
,
C. Achour
,
F. Ader
,
et al.
Journal articles
hal-02546158v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Disability Progression in Multiple Sclerosis Patients using Early First-line Treatments
Mathilde Lefort
,
Sandra Vukusic
,
Romain Casey
,
Gilles Edan
,
Emmanuelle Leray
Journal articles
hal-03690316v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: A 5-year prospective study
Emmanuelle Le Page
,
Emmanuelle Leray
,
Gilles Edan
Journal articles
hal-02437110v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Parcours de soins des patients atteints de sclérose en plaques à partir des données médico-administratives en France
Jonathan Roux
Theses
tel-02379451v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system
Camille Sabathé
,
Romain Casey
,
Sandra Vukusic
,
Emmanuelle Leray
,
Guillaume Mathey
,
et al.
Journal articles
hal-04086418v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
M. Lefort
,
S. Sharmin
,
J. Andersen
,
S. Vukusic
,
R. Casey
,
et al.
Journal articles
hal-03690493v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis
Kevin Ahrweiller
,
Chloé Rousseau
,
Emmanuelle Le Page
,
Emma Bajeux
,
Emmanuelle Leray
,
et al.
Journal articles
hal-02150346v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Multichannel sequence analysis: An innovative method to study patterns of care pathways. Application to multiple sclerosis based on French Health Insurance data
Jonathan Roux
,
Olivier Grimaud
,
Emmanuelle Leray
Journal articles
hal-02921552v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice
Laura Couloume
,
Laetitia Barbin
,
Emmanuelle Leray
,
Sandrine Wiertlewski
,
Emmanuelle Le Page
,
et al.
Journal articles
hal-02436685v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long‐term effect of first‐line injectable multiple sclerosis treatments: input of a time‐dependent propensity score
Mathilde Lefort
,
Yohann Foucher
,
Rémi Lenain
,
Sandra Vukusic
,
Gilles Edan
,
et al.
Journal articles
hal-02979802v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Assessing environmental epidemiology questions in practice with a causal inference pipeline: An investigation of the air pollution-multiple sclerosis relapses relationship
Alice J. Sommer
,
Emmanuelle Leray
,
Young Lee
,
Marie-Abele C. Bind
Journal articles
hal-03101469v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Use of state sequence analysis for care pathway analysis: The example of multiple sclerosis
Jonathan Roux
,
Olivier Grimaud
,
Emmanuelle Leray
Journal articles
hal-01798652v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study
Soline Leblanc
,
Jonathan Roux
,
Hélène Tillaut
,
Emmanuelle Le Page
,
Emmanuelle Leray
Journal articles
hal-03312766v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Care-seeking of patients with multiple sclerosis over 2010-2015 in France - a nationwide study using health administrative data
Jonathan Roux
,
A. Guilleux
,
Olivier Grimaud
,
Emmanuelle Leray
Multiple Sclerosis Journal, 2018, 24, pp.550-551
Journal articles
hal-01935074v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, Canada
Jonathan Roux
,
Elaine Kingwell
,
Feng Zhu
,
Helen Tremlett
,
Emmanuelle Leray
Journal articles
hal-03246670v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France
Soline Leblanc
,
Mathilde Lefort
,
Emmanuelle Le Page
,
Laure Michel
,
Emmanuelle Leray
Journal articles
hal-03629848v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Determinants of Therapeutic Lag in Multiple Sclerosis
Izanne Roos
,
Emmanuelle Leray
,
Federico Frascoli
,
Romain Casey
,
J William L Brown
,
et al.
Journal articles
hal-03223056v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Identification of Therapeutic Lag in Multiple Sclerosis
Izanne Roos
,
Emmanuelle Leray
,
Federico Frascoli
,
Romain Casey
,
Dana Horakova
,
et al.
Neurology, 2020, 94 (15)
Journal articles
hal-02929403v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis
Marie Mainguy
,
Hélène Tillaut
,
Adeline Degremont
,
Emmanuelle Le Page
,
Christelle Mainguy
,
et al.
Journal articles
hal-03751891v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
C Walton
,
Rachel King
,
Lindsay Rechtman
,
Wendy Kaye
,
Emmanuelle Leray
,
et al.
Journal articles
hal-03038709v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A new treatment era in multiple sclerosis: Clinical applications of new concepts
Gilles Edan
,
Emmanuelle Leray
Journal articles
istex
hal-02437067v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies
Hélène Tillaut
,
Adeline Degrémont
,
Sandrine Kerbrat
,
Jonathan Roux
,
Emmanuelle Le Page
,
et al.
Journal articles
hal-03819581v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Geographical variations in access to expert centers for multiple sclerosis in France
Emmanuelle Leray
,
F. Mamadou
,
A. Guilleux
,
Jonathan Roux
,
Olivier Grimaud
Journal articles
hal-02470788v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients
Soizic Leguy
,
Mathilde Lefort
,
Lucile Lescot
,
Audrey Michaud
,
Sandra Vukusic
,
et al.
Journal articles
hal-03704177v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|